Critical shifts in stroke emergency protocols could dramatically alter outcomes for millions of patients annually. Three pivotal trials challenge established treatment hierarchies while confirming others, potentially redefining care standards across emergency departments worldwide.
Three randomized trials definitively showed endovascular thrombectomy provides no benefit over optimal medical therapy for medium vessel occlusion strokes, contradicting widespread clinical assumptions. Conversely, pre-treatment with intravenous tenecteplase before thrombectomy significantly improved 90-day functional independence in large vessel occlusion patients compared to thrombectomy alone. Most significantly for hemorrhagic strokes, individual patient data from four trials confirmed intensive blood pressure reduction within three hours of intracerebral hemorrhage onset safely enhanced functional recovery.
These findings represent a watershed moment in acute stroke management. The medium vessel occlusion results will likely curtail expensive, invasive procedures for thousands of patients annually while redirecting resources toward proven medical therapies. The tenecteplase findings suggest combination approaches may optimize outcomes for large vessel strokes, though implementation requires careful protocol refinement. The hemorrhagic stroke blood pressure data finally provides definitive evidence for aggressive early intervention, resolving years of clinical uncertainty. However, the three-hour window creates significant logistical challenges for emergency systems. While individually rigorous, these single trials require replication before wholesale practice changes. The convergence of evidence across different stroke subtypes suggests stroke medicine is entering a more precise, protocol-driven era that could substantially improve population outcomes.